UB Paderborn / Katalog / Suche / in CDI

1 – 24 von 24

Sortiert nach

Augmented neutralisation resistance of emerging omicron subvariants BA.2.12.1, BA.4, and BA.5

The Lancet infectious diseases, 2022-08, Vol.22 (8), p.1117-1118

2022

Link zum Volltext

Verfügbarkeit prüfen

Neutralization of the SARS-CoV-2 Delta variant after heterologous and homologous BNT162b2 or ChAdOx1 nCoV-19 vaccination

Cellular & molecular immunology, 2021-10, Vol.18 (10), p.2455-2456

2021

Link zum Volltext

Verfügbarkeit prüfen

Delta variant (B.1.617.2) sublineages do not show increased neutralization resistance

Cellular & molecular immunology, 2021-11, Vol.18 (11), p.2557-2559

2021

Link zum Volltext

Verfügbarkeit prüfen

The spike protein of SARS-CoV-2 variant A.30 is heavily mutated and evades vaccine-induced antibodies with high efficiency

Cellular & molecular immunology, 2021-12, Vol.18 (12), p.2673-2675

2021

Link zum Volltext

Verfügbarkeit prüfen

Inhibitors of signal peptide peptidase and subtilisin/kexin-isozyme 1 inhibit Ebola virus glycoprotein-driven cell entry by interfering with activity and cellular localization of endosomal cathepsins

PloS one, 2019-04, Vol.14 (4), p.e0214968-e0214968

2019

Link zum Volltext

Verfügbarkeit prüfen

Non-human primate orthologues of TMPRSS2 cleave and activate the influenza virus hemagglutinin

PloS one, 2017-05, Vol.12 (5), p.e0176597

2017

Link zum Volltext

Verfügbarkeit prüfen

TMPRSS2 Is Essential for SARS-CoV-2 Beta and Omicron Infection

Viruses, 2023-01, Vol.15 (2), p.271

2023

Link zum Volltext

Verfügbarkeit prüfen

Efficient antibody evasion but reduced ACE2 binding by the emerging SARS-CoV-2 variant B.1.640.2

Cellular & molecular immunology, 2022-09, Vol.19 (9), p.1067-1069

2022

Link zum Volltext

Verfügbarkeit prüfen

Effect of hybrid immunity and bivalent booster vaccination on omicron sublineage neutralisation

The Lancet infectious diseases, 2023-01, Vol.23 (1), p.25-28

2023

Link zum Volltext

Verfügbarkeit prüfen

Influenza A virus does not encode a tetherin antagonist with Vpu-like activity and induces IFN-dependent tetherin expression in infected cells

PloS one, 2012-08, Vol.7 (8), p.e43337-e43337

2012

Link zum Volltext

Verfügbarkeit prüfen

The SARS-CoV-2 Delta-Omicron Recombinant Lineage (XD) Exhibits Immune-Escape Properties Similar to the Omicron (BA.1) Variant

International journal of molecular sciences, 2022-11, Vol.23 (22), p.14057

2022

Link zum Volltext

Verfügbarkeit prüfen

Role of rhesus macaque IFITM3(2) in simian immunodeficiency virus infection of macaques

PloS one, 2019-11, Vol.14 (11), p.e0224082-e0224082

2019

Link zum Volltext

Verfügbarkeit prüfen

H2 influenza A virus is not pathogenic in Tmprss2 knock-out mice

Virology journal, 2020-04, Vol.17 (1), p.56-56, Article 56

2020

Link zum Volltext

Verfügbarkeit prüfen

Neutralisation sensitivity of SARS-CoV-2 lineages EG.5.1 and XBB.2.3

The Lancet infectious diseases, 2023-10, Vol.23 (10), p.e391-e392

2023

Link zum Volltext

Verfügbarkeit prüfen

Lung cell entry, cell–cell fusion capacity, and neutralisation sensitivity of omicron sublineage BA.2.75

The Lancet infectious diseases, 2022-11, Vol.22 (11), p.1537-1538

2022

Link zum Volltext

Verfügbarkeit prüfen

Native and activated antithrombin inhibits TMPRSS2 activity and SARS‐CoV‐2 infection

Journal of medical virology, 2023-01, Vol.95 (1), p.e28124-n/a

2023

Link zum Volltext

Verfügbarkeit prüfen

The effect of cilgavimab and neutralisation by vaccine-induced antibodies in emerging SARS-CoV-2 BA.4 and BA.5 sublineages

The Lancet infectious diseases, 2022-12, Vol.22 (12), p.1665-1666

2022

Link zum Volltext

Verfügbarkeit prüfen

Mutagenic Analysis of the HIV Restriction Factor Shiftless

Viruses, 2022-06, Vol.14 (7), p.1454

2022

Link zum Volltext

Verfügbarkeit prüfen

Being ready for the next influenza pandemic?

The Lancet infectious diseases, 2023-04, Vol.23 (4), p.398-399

2023

Link zum Volltext

Verfügbarkeit prüfen

Avian influenza overview December 2022 – March 2023

EFSA journal, 2023-03, Vol.21 (3), p.e07917-n/a

2023

Link zum Volltext

Verfügbarkeit prüfen

Avian influenza overview September–December 2023

EFSA journal, 2023-12, Vol.21 (12), p.e8539-n/a

2023

Link zum Volltext

Verfügbarkeit prüfen

Screening for Influenza and Morbillivirus in Seals and Porpoises in the Baltic and North Sea

Pathogens (Basel), 2023-02, Vol.12 (3), p.357

2023

Link zum Volltext

Verfügbarkeit prüfen

Avian influenza overview December 2023–March 2024

EFSA journal, 2024-03, Vol.22 (3), p.e8754-n/a

2024

Link zum Volltext

Verfügbarkeit prüfen

1 – 24 von 24

Suche als RSS-Feed

Aktive Filter

ThemaInfections

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(23)
Mit Volltextzugriff
(24)

Publikationsform

Artikel
(24)

Sprache

Englisch
(24)

Erscheinungsjahr

n.n

Thema

Science & Technology
(23)
Life Sciences & Biomedicine
(19)
Humans
(16)
Proteins
(16)
Viruses
(15)
Severe Acute Respiratory Syndrome Coronavirus 2
(13)
Coronaviruses
(10)
Influenza
(10)
Pandemics
(10)
Antibodies
(9)
Correspondence
(8)
Covid-19 Vaccines
(8)
Mutation
(8)
Virology
(8)
Animals
(6)
Avian Flu
(6)
Infectious Diseases
(6)
Efficiency
(5)
Hek293 Cells
(5)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Augmented neutralisation resistance of emerging omicron subvariants BA.2.12.1, BA.4, and BA.5

Neutralization of the SARS-CoV-2 Delta variant after heterologous and homologous BNT162b2 or ChAdOx1 nCoV-19 vaccination

Delta variant (B.1.617.2) sublineages do not show increased neutralization resistance

The spike protein of SARS-CoV-2 variant A.30 is heavily mutated and evades vaccine-induced antibodies with high efficiency

Inhibitors of signal peptide peptidase and subtilisin/kexin-isozyme 1 inhibit Ebola virus glycoprotein-driven cell entry by interfering with activity and cellular localization of endosomal cathepsins

Non-human primate orthologues of TMPRSS2 cleave and activate the influenza virus hemagglutinin

TMPRSS2 Is Essential for SARS-CoV-2 Beta and Omicron Infection

Efficient antibody evasion but reduced ACE2 binding by the emerging SARS-CoV-2 variant B.1.640.2

Effect of hybrid immunity and bivalent booster vaccination on omicron sublineage neutralisation

Influenza A virus does not encode a tetherin antagonist with Vpu-like activity and induces IFN-dependent tetherin expression in infected cells

The SARS-CoV-2 Delta-Omicron Recombinant Lineage (XD) Exhibits Immune-Escape Properties Similar to the Omicron (BA.1) Variant

Role of rhesus macaque IFITM3(2) in simian immunodeficiency virus infection of macaques

H2 influenza A virus is not pathogenic in Tmprss2 knock-out mice

Neutralisation sensitivity of SARS-CoV-2 lineages EG.5.1 and XBB.2.3

Lung cell entry, cell–cell fusion capacity, and neutralisation sensitivity of omicron sublineage BA.2.75

Native and activated antithrombin inhibits TMPRSS2 activity and SARS‐CoV‐2 infection

The effect of cilgavimab and neutralisation by vaccine-induced antibodies in emerging SARS-CoV-2 BA.4 and BA.5 sublineages

Mutagenic Analysis of the HIV Restriction Factor Shiftless

Being ready for the next influenza pandemic?

Avian influenza overview December 2022 – March 2023

Avian influenza overview September–December 2023

Screening for Influenza and Morbillivirus in Seals and Porpoises in the Baltic and North Sea

Avian influenza overview December 2023–March 2024

The role of mammals in Avian Influenza: a review

Aktive Filter

Suchergebnisse filtern